AN2 Therapeutics, Inc., (ANTX): Price and Financial Metrics
ANTX Price/Volume Stats
| Current price | $1.27 | 52-week high | $21.40 |
| Prev. close | $1.27 | 52-week low | $0.87 |
| Day low | $1.26 | Volume | 89,700 |
| Day high | $1.29 | Avg. volume | 116,309 |
| 50-day MA | $1.31 | Dividend yield | N/A |
| 200-day MA | $1.73 | Market Cap | 37.95M |
ANTX Stock Price Chart Interactive Chart >
AN2 Therapeutics, Inc., (ANTX) Company Bio
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.
ANTX Price Returns
| 1-mo | 0.79% |
| 3-mo | 17.59% |
| 6-mo | -51.89% |
| 1-year | -93.31% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -7.97% |
| 2024 | -93.27% |
| 2023 | 115.01% |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
Loading social stream, please wait...